Yonghe Medical Group Management
Management criteria checks 2/4
Yonghe Medical Group's CEO is Yu Zhang, appointed in Jul 2010, has a tenure of 15.25 years. total yearly compensation is CN¥2.18M, comprised of 74.7% salary and 25.3% bonuses, including company stock and options. directly owns 34.56% of the company’s shares, worth HK$352.62M. The average tenure of the management team and the board of directors is 3.9 years and 4.3 years respectively.
Key information
Yu Zhang
Chief executive officer
CN¥2.2m
Total compensation
| CEO salary percentage | 74.75% |
| CEO tenure | 15.3yrs |
| CEO ownership | 34.6% |
| Management average tenure | 3.9yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
What You Can Learn From Yonghe Medical Group Co., Ltd.'s (HKG:2279) P/S After Its 26% Share Price Crash
Sep 23
There's Reason For Concern Over Yonghe Medical Group Co., Ltd.'s (HKG:2279) Massive 62% Price Jump
Aug 04Shareholders May Be Wary Of Increasing Yonghe Medical Group Co., Ltd.'s (HKG:2279) CEO Compensation Package
Jun 13What Yonghe Medical Group Co., Ltd.'s (HKG:2279) 32% Share Price Gain Is Not Telling You
May 15Yonghe Medical Group Co., Ltd. (HKG:2279) Stock Catapults 31% Though Its Price And Business Still Lag The Industry
Mar 07Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Bounce 36% But Its Business Still Trails The Industry
Dec 12Yonghe Medical Group Co., Ltd.'s (HKG:2279) Shares Leap 60% Yet They're Still Not Telling The Full Story
Sep 30Is Yonghe Medical Group (HKG:2279) Using Debt Sensibly?
May 24It's Down 34% But Yonghe Medical Group Co., Ltd. (HKG:2279) Could Be Riskier Than It Looks
Mar 31Are Yonghe Medical Group Co., Ltd. (HKG:2279) Investors Paying Above The Intrinsic Value?
Oct 19The Consensus EPS Estimates For Yonghe Medical Group Co., Ltd. (HKG:2279) Just Fell Dramatically
Sep 08Is Yonghe Medical Group Co., Ltd. (HKG:2279) Expensive For A Reason? A Look At Its Intrinsic Value
Aug 19Yonghe Medical Group's (HKG:2279) Soft Earnings Don't Show The Whole Picture
Mar 31CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2025 | n/a | n/a | -CN¥60m |
| Mar 31 2025 | n/a | n/a | -CN¥143m |
| Dec 31 2024 | CN¥2m | CN¥2m | -CN¥226m |
| Sep 30 2024 | n/a | n/a | -CN¥346m |
| Jun 30 2024 | n/a | n/a | -CN¥464m |
| Mar 31 2024 | n/a | n/a | -CN¥505m |
| Dec 31 2023 | CN¥2m | CN¥2m | -CN¥546m |
| Sep 30 2023 | n/a | n/a | -CN¥434m |
| Jun 30 2023 | n/a | n/a | -CN¥322m |
| Mar 31 2023 | n/a | n/a | -CN¥203m |
| Dec 31 2022 | CN¥1m | CN¥1m | -CN¥84m |
| Sep 30 2022 | n/a | n/a | CN¥6m |
| Jun 30 2022 | n/a | n/a | CN¥95m |
| Mar 31 2022 | n/a | n/a | CN¥107m |
| Dec 31 2021 | CN¥1m | CN¥1m | CN¥118m |
| Sep 30 2021 | n/a | n/a | CN¥121m |
| Jun 30 2021 | n/a | n/a | CN¥125m |
| Mar 31 2021 | n/a | n/a | CN¥136m |
| Dec 31 2020 | CN¥5m | CN¥1m | CN¥147m |
| Dec 31 2019 | CN¥1m | CN¥900k | CN¥36m |
| Dec 31 2018 | CN¥580k | CN¥455k | CN¥54m |
Compensation vs Market: Yu's total compensation ($USD306.31K) is above average for companies of similar size in the Hong Kong market ($USD232.31K).
Compensation vs Earnings: Yu's compensation has increased whilst the company is unprofitable.
CEO
Yu Zhang (39 yo)
Mr. Yu Zhang is Chairman of the Board, Executive Director & CEO of Yonghe Medical Group Co., Ltd. He joined the Yonghe Medical Group Co., Ltd. in July 2010.He is Founder of onghe Medical Group Co., Ltd. M...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 15.3yrs | CN¥2.18m | 34.56% HK$ 352.6m | |
| Executive Director | 8.6yrs | CN¥1.08m | 0.069% HK$ 704.3k | |
| Senior VP of the Integrated Management Center & Executive Director | 4.3yrs | CN¥1.08m | 4.62% HK$ 47.2m | |
| Chief Executive Officer of Innovation Business Unit | 2.4yrs | no data | no data | |
| Chief Growth Officer | 3.4yrs | no data | no data | |
| Joint Company Secretary | 1.2yrs | no data | no data |
Experienced Management: 2279's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board & CEO | 5.1yrs | CN¥2.18m | 34.56% HK$ 352.6m | |
| Executive Director | 3.3yrs | CN¥1.08m | 0.069% HK$ 704.3k | |
| Senior VP of the Integrated Management Center & Executive Director | 5.1yrs | CN¥1.08m | 4.62% HK$ 47.2m | |
| Independent Non-Executive Director | 4.3yrs | CN¥182.00k | no data | |
| Independent Non-Executive Director | 3.3yrs | CN¥183.00k | no data | |
| Non-Executive Director | 5.1yrs | no data | 0.13% HK$ 1.3m | |
| Independent Non-Executive Director | 4.3yrs | CN¥183.00k | no data |
Experienced Board: 2279's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/22 02:39 |
| End of Day Share Price | 2025/10/22 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Yonghe Medical Group Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yichi Zhang | China International Capital Corporation Limited |
| Liting Wang | Haitong International Research Limited |
| Wenzheng Liu | Minsheng Securities Co. |